Prenatal Testing Market Growth, Global Survey, Analysis, Share, Company Profiles and Forecast by 2027
The market is poised to expand exponentially over the projected timeframe due to the escalating incidences of chromosomal defects with the rising maternal age. Every year nearly 10-15% of clinically reported pregnancies end in miscarriages, with chromosomal defects observed in approximately 50% of cases.
The
Prenatal Testing Market is expected to be valued at USD 8.08 Billion by 2027
from USD 3.23 Billion in 2019, registering a CAGR of 12.9% through the forecast
period.
To
get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/prenatal-testing-market
Scope
of the Report:
The
study finds that how on certain account threats and challenges can act as a
roadblock for the business. A thorough evaluation of the Prenatal Testing market
in the light of macro-environment such as social, political, economical as well
as technological environment add granularity to the overall research. In
addition, the study produces real-time data on vital aspects including sales,
profits, gross margin and growth prospects to show how going forward the
business will witness a substantial upswing.
Major
players in the global market include Quest Diagnostics, Natera, Inc., GeneDx,
Inc., Illumina, Inc., Prenatal Paternities Inc., Ravgen Inc., Ariosa Diagnostics,
Inc., Counsyl, Inc., LabCorp, and Eurofins NTD Inc., among others.
Key Highlights from Report:
-
Quest Diagnostics
acquired Blueprint Genetics Oy in January 2020. The consolidation of Blueprint
Genetics into the Quest Diagnostics’ portfolio will expand and improve the
Quest Value Proposition, contributing to its accelerated development schedule.
For
the purpose of this report, Emergen Research has segmented the Global Prenatal
Testing Market on the basis of method, test type, application, end-use, and
region:
Regional Outlook (Revenue, USD Billion; 2017-2027)
·
North America
o U.S.
o Canada
o Mexico
·
Europe
o Germany
o U.K.
o France
o BENELUX
o Rest
of Europe
·
Asia Pacific
o China
o Japan
o South
Korea
o India
o Rest
of APAC
·
Latin America
o Brazil
o Rest
of LATAM
·
Middle East & Africa
o Saudi
Arabia
o U.A.E.
o South
Africa
o
Rest of MEA
Contact Us:
Corporate Sales Specialist
Emergen
Research | Web: www.emergenresearch.com
Direct
Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Comments
Post a Comment